CCXI

ChemoCentryx Inc.

This asset is no longer available for investment.

View all assets

Price

$12.62

return (12m)

p/e

-5.36

p/bv

-4.62

DIVIDEND YIELD

0.00%

CCXI price

ChemoCentryx

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CCXI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-10.43%

3 months

22.46%

1 year

0.00%

2 years

0.00%

5 years

-23.84%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CCXI

Valuation

P/E

-5.36

Sector -3.52

Industry -3.52

P/BV

-4.62

Sector 2.04

Industry 2.04

P/Revenue (PSR)

Sector 2.02

Industry 2.02

EV/EBITDA

Sector -223.26

Industry -223.26

EV/EBIT

Sector -47.66

Industry -47.66

P/EBITDA

-17.57

Sector -21.38

Industry -21.38

P/EBIT

-17.57

Sector -28.46

Industry -28.46

P/Total Assets

1.67

Sector 1.19

Industry 1.19

P/Net Current Assets

-4.62

Sector -10.28

Industry -10.28

P/Working Capital

-5.10

Sector -169.36

Industry -169.36

EPS

-2.36

Sector -1.81

Industry -1.81

BVPS

-2.74

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

0.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

0.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

0.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

Sector 0.02

Industry 0.02

Profitability

ROE

86.19%

Sector -56.04%

Industry -56.04%

ROA

-31.12%

Sector -60.31%

Industry -60.31%

ROIC

-32.55%

Sector -2,355.96%

Industry -2,355.96%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.01

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -14,081,727.50

Industry -14,081,727.50

Net Debt / EBIT

Sector -8.06

Industry -8.06

Net Debt / Equity

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

Sector -0.85

Industry -0.85

Equity/Assets

-0.36

Sector 0.46

Industry 0.46

Liabilities/Assets

0.37

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals CCXI

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CCXI ChemoCentryx Inc.	$12.62	-	0.00%	-5.36	-4.62	86.19%	0.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.98%	30.47	7.54	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.24%	35.93	1.84	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.65%	72.22	-76.87	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.09%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	2.03%	19.00	4.89	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	42.33%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.25%	26.93	20.14	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	30.46	87.77	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.88%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.61	3.00	114.60%	44.55%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.26	2.41	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CCXI Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ChemoCentryx

ChemoCentryx Inc.

Average Investor10 user rating

4.0 (1 people)

United States

30 years

Founded: 1996

2012

Time since IPO - 14 years

133

Employees

ChemoCentryx Inc. (United States) is listed on the Nasdaq and has a market capitalization of $705.13 million, with shareholders equity totaling $-152.60 million.

The company employs approximately 133 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, ChemoCentryx Inc. reported $- in revenue, generating net income of $-131.53 million.

Key financial metrics include a P/E ratio of -5.36, a price-to-book (P/B) ratio of -4.62, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CCXI.

Market cap

$705.13 million

Net worth

$-152.60 million

$-152,600,000.00

Assets

$422.64 million

$422,637,000.00

Total Shares Outstanding

55.65 million

55,653,000

Average Daily Trading Volume

$2.96 million

$2,958,102.00

Sector

Health Care

Industry

Biotechnology

CCXI

CCXI revenue and profits

Financial Results CCXI

DRAG THE FRAME TO SEE MORE DATA

CCXI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,90% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$224.45 51,94% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.47

1.98%

ROE

24.76%

P/BV

7.54

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

72.22

2.65%

ROE

-106.44%

P/BV

-76.87

MRK - Merck & Co.

$146.11 86,25% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.00

2.03%

ROE

25.77%

P/BV

4.89

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.93

6.24%

ROE

5.11%

P/BV

1.84

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,90% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$224.45 51,94% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.47

1.98%

ROE

24.76%

P/VP

7.54

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

72.22

2.65%

ROE

-106.44%

P/VP

-76.87

MRK - Merck & Co.

$146.11 86,25% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.00

2.03%

ROE

25.77%

P/VP

4.89

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.93

6.24%

ROE

5.11%

P/VP

1.84

Frequently Asked Questions

What is the price of ChemoCentryx (CCXI) today?

A cotação de ChemoCentryx (CCXI) hoje está em US$ 12.62, com uma variação de 0% em relação ao último ano. A cotação de ChemoCentryx (CCXI) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 12.62. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de ChemoCentryx (CCXI) e dados de ações do Ibovespa e mercados internacionais.

Quando ChemoCentryx (CCXI) paga dividendos?

ChemoCentryx (CCXI) não distribuiu dividendos no último ano.

Is ChemoCentryx (CCXI) a good investment?

Atualmente, ChemoCentryx (CCXI) está cotada a US$ 12.62, com um P/L de -5.36, representando um desvio de -268% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy ChemoCentryx (CCXI) stock?

Investir em ações de ChemoCentryx (CCXI) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of ChemoCentryx (CCXI) yield today?

A rentabilidade de ChemoCentryx (CCXI) foi de -10.43% no último mês, 0.00% no último ano e -23.84% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de ChemoCentryx (CCXI) hoje, o investimento total seria de US$ 1,262.00, com base na cotação atual de US$ 12.62.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,262.00
Em 5 anos: US$ 961.14
Em 10 anos: US$ 1,262.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CCXI

ChemoCentryx Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CCXI

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING CCXI WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT ChemoCentryx

ChemoCentryx Inc.

United States

30 years

2012

133

Financial Results CCXI

CCXI cash flow

Asset, Revenue and Profit Growth - CCXI

CCXI balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions